Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
834,731,296
-
Number of holders
-
161
-
Total 13F shares, excl. options
-
27,315,628
-
Shares change
-
+251,797
-
Total reported value, excl. options
-
$1,237,695,092
-
Value change
-
+$11,132,499
-
Put/Call ratio
-
1.12%
-
Number of buys
-
59
-
Number of sells
-
-76
-
Price
-
$45.28
Significant Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q4 2016
176 filings reported holding RDY - DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share as of Q4 2016.
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) has 161 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27,315,628 shares
of 834,731,296 outstanding shares and own 3.27% of the company stock.
Largest 10 shareholders include Fisher Asset Management, LLC (5,621,898 shares), COMMONWEALTH BANK OF AUSTRALIA (3,841,047 shares), ROYAL BANK OF CANADA (2,526,656 shares), AQR CAPITAL MANAGEMENT LLC (2,293,685 shares), VANGUARD GROUP INC (1,470,459 shares), VONTOBEL ASSET MANAGEMENT INC (1,199,944 shares), BlackRock Group LTD (888,938 shares), JPMORGAN CHASE & CO (648,822 shares), DIMENSIONAL FUND ADVISORS LP (638,315 shares), and HSBC HOLDINGS PLC (636,346 shares).
This table shows the top 161 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.